Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs LASA SUPERGENERICS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB LASA SUPERGENERICS DR. REDDYS LAB/
LASA SUPERGENERICS
 
P/E (TTM) x 19.7 -5.1 - View Chart
P/BV x 4.4 0.9 476.8% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 DR. REDDYS LAB   LASA SUPERGENERICS
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-23
LASA SUPERGENERICS
Mar-23
DR. REDDYS LAB/
LASA SUPERGENERICS
5-Yr Chart
Click to enlarge
High Rs4,65665 7,174.0%   
Low Rs3,78817 21,956.8%   
Sales per share (Unadj.) Rs1,481.425.9 5,728.1%  
Earnings per share (Unadj.) Rs270.7-7.7 -3,511.1%  
Cash flow per share (Unadj.) Rs345.7-5.0 -6,873.0%  
Dividends per share (Unadj.) Rs40.000-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs1,389.623.6 5,885.5%  
Shares outstanding (eoy) m166.5350.10 332.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.81.6 179.4%   
Avg P/E ratio x15.6-5.3 -292.7%  
P/CF ratio (eoy) x12.2-8.2 -149.5%  
Price / Book Value ratio x3.01.7 174.6%  
Dividend payout %14.80-   
Avg Mkt Cap Rs m703,0392,058 34,162.8%   
No. of employees `000NANA-   
Total wages/salary Rs m46,46674 63,064.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m246,6971,296 19,040.0%  
Other income Rs m10,55518 57,270.8%   
Total revenues Rs m257,2521,314 19,576.1%   
Gross profit Rs m63,860-265 -24,101.8%  
Depreciation Rs m12,502134 9,316.6%   
Interest Rs m1,42842 3,404.9%   
Profit before tax Rs m60,485-423 -14,310.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,412-36 -42,294.2%   
Profit after tax Rs m45,073-386 -11,670.6%  
Gross profit margin %25.9-20.4 -126.6%  
Effective tax rate %25.58.6 295.5%   
Net profit margin %18.3-29.8 -61.3%  
BALANCE SHEET DATA
Current assets Rs m203,161392 51,799.0%   
Current liabilities Rs m85,721427 20,062.0%   
Net working cap to sales %47.6-2.7 -1,758.6%  
Current ratio x2.40.9 258.2%  
Inventory Days Days793 2,726.5%  
Debtors Days Days10770 153.6%  
Net fixed assets Rs m112,6381,246 9,037.5%   
Share capital Rs m833501 166.3%   
"Free" reserves Rs m230,571682 33,815.5%   
Net worth Rs m231,4041,183 19,563.1%   
Long term debt Rs m1,2780-   
Total assets Rs m315,7991,639 19,273.1%  
Interest coverage x43.4-9.1 -477.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.8 98.8%   
Return on assets %14.7-21.0 -70.1%  
Return on equity %19.5-32.7 -59.7%  
Return on capital %26.6-32.2 -82.7%  
Exports to sales %52.24.8 1,094.1%   
Imports to sales %16.80.4 4,275.5%   
Exports (fob) Rs m128,80362 208,318.0%   
Imports (cif) Rs m41,4845 813,411.8%   
Fx inflow Rs m128,80362 208,318.0%   
Fx outflow Rs m41,4845 813,411.8%   
Net fx Rs m87,31957 153,920.3%   
CASH FLOW
From Operations Rs m58,875-173 -34,031.8%  
From Investments Rs m-41,373112 -36,956.7%  
From Financial Activity Rs m-26,861-42 64,554.2%  
Net Cashflow Rs m-9,073-103 8,837.9%  

Share Holding

Indian Promoters % 26.7 53.7 49.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 47.3 0.0 472,700.0%  
FIIs % 28.6 0.0 286,200.0%  
ADR/GDR % 15.3 0.0 -  
Free float % 58.0 46.4 125.2%  
Shareholders   257,794 27,161 949.1%  
Pledged promoter(s) holding % 0.0 20.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Dr. Reddys vs LASA SUPERGENERICS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dr. Reddys vs LASA SUPERGENERICS Share Price Performance

Period Dr. Reddys LASA SUPERGENERICS S&P BSE HEALTHCARE
1-Day 1.78% 0.60% 1.18%
1-Month -4.23% -26.69% -0.75%
1-Year 35.93% 23.98% 61.82%
3-Year CAGR 10.85% -28.71% 18.16%
5-Year CAGR 17.77% -0.56% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dr. Reddys share price and the LASA SUPERGENERICS share price.

Moving on to shareholding structures...

The promoters of Dr. Reddys hold a 26.7% stake in the company. In case of LASA SUPERGENERICS the stake stands at 53.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dr. Reddys and the shareholding pattern of LASA SUPERGENERICS.

Finally, a word on dividends...

In the most recent financial year, Dr. Reddys paid a dividend of Rs 40.0 per share. This amounted to a Dividend Payout ratio of 14.8%.

LASA SUPERGENERICS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Dr. Reddys, and the dividend history of LASA SUPERGENERICS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.